The combined serum levels of<i>miR-375</i>and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancerSven Wach, Helge Täubert, Gerit Theil et al.|International Journal of Cancer|2015Cited by 53
Salivary miR-93 and miR-200a as post-radiotherapy biomarkers in head and neck squamous cell carcinomaThomas Greither, Alexander W. Eckert, Jeremias Hey et al.|Oncology Reports|2017Cited by 45
Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer PatientsAlexander Fichte, Verena Lieb, Angela Neumann et al.|Life|2022Cited by 3